12:00 AM
 | 
May 14, 2012
 |  BC Week In Review  |  Company News  |  Deals

AmniSure International LLC, Qiagen deal

Qiagen acquired AmniSure, which markets the AmniSure assay to determine whether a pregnant woman is suffering rupture of fetal membranes, where fluid leaks prematurely from the amniotic sac. The assay, which detects tiny...

Read the full 141 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >